# Study of DAA Treatment for Children and Adolescents With Active HCV Infection in Cambodia

> **NCT05992077** · NA · ACTIVE_NOT_RECRUITING · sponsor: **ANRS, Emerging Infectious Diseases** · enrollment: 21000 (estimated)

## Conditions studied

- HCV Infection

## Interventions

- **DRUG:** Sofosbuvir/Daclatasvir

## Key facts

- **NCT ID:** NCT05992077
- **Lead sponsor:** ANRS, Emerging Infectious Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-08-07
- **Primary completion:** 2026-01-31
- **Final completion:** 2026-01-31
- **Target enrollment:** 21000 (ESTIMATED)
- **Last updated:** 2025-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05992077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05992077, "Study of DAA Treatment for Children and Adolescents With Active HCV Infection in Cambodia". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT05992077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*